---
title: "teclistamab"
date: "2024-07-27"
tags:
  - building
---

> [!NOTE]
> ðŸŒ± created from: [[bite_rrmm]]

# teclistamab

MajesTEC-1: pivotal, open-label, phase I/II trial of teclistamab in R/R MM

- Median time to first response: 1.2mo
- Median time to best response: 3.8mo
- Long-term
  - median follow-up:23mo
